News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
AppYea Launches Smart Biofeedback-Based Wristband to Address Snoring
Press Release | 09/30/2024
https://www.otcmarkets.com/stock/APYP/news/AppYea-Launches-Smart-Biofeedback-Based-Wristband-to-Address-Snoring?id=454333
$APYP A new online store has gone live:
$APYP
— AppySleep (OTCQB: APYP) (@SleepXclear) September 4, 2024
A new online store has gone live: https://t.co/GwQDlEWkf3
Experience a new era of restful nights with AppySleep non-intrusive anti snoring solution. pic.twitter.com/dNOAUcMzZI
The Amazon store is also down today. It was up as of yesterday showing item was out of stock. Now it can't be found. Are they reworking the store today? Getting ready to restock the new version?
$APYP Updated on Aug 27, 2024 https://play.google.com/store/apps/details?id=com.matrix.sleepx&hl=en_US
Form 10-Q - Quarterly report is out.
Still shows unavailable. The last PR, iirc said July we see them restocked. Should be any day, imo.
I hope we see news soon.
https://www.amazon.com/dp/B0CTMNHQBX?ref=myi_title_dp
AppySleep by Mendix.
A new partner maybe?
Did they license it?
Mendix is big!
$APYP
A new app for iOS and Android with upgraded algorithms and additional functions and a new design will soon be available in Google and Apple stores. Be ready, we will update soon.
$APYP
— AppySleep (OTCQB: APYP) (@SleepXclear) June 4, 2024
A new app for iOS and Android with upgraded algorithms and additional functions and a new design will soon be available in Google and Apple stores. Be ready, we will update soon. pic.twitter.com/AziNeUDXBJ
Looks like both the company store and the store on Amazon are all out of Appysleep. Sold out. Time to reorder.
Keep an eye on when it's restocked. That should be a good indicator when the Apple version is being released.
$APYP A new app for iOS and Android with upgraded algorithms and additional functions and a new design will soon be available in Google and Apple stores. Be ready, we will update soon.
$APYP
— AppySleep (OTCQB: APYP) (@SleepXclear) June 4, 2024
A new app for iOS and Android with upgraded algorithms and additional functions and a new design will soon be available in Google and Apple stores. Be ready, we will update soon. pic.twitter.com/AziNeUDXBJ
They sell through Amazon as well as their own website. They have more they one place to sell online.
Looks like hefty sales cleared them out. Reordering should be easy now that the product is on the market.
Form 10-Q has been filed.
Sales must be good.
$APYP
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / AppYea Inc. (OTCQB:APYP), developer of an innovative wearable monitoring solution to monitor and treat sleep apnea and snoring, today announced the conversion of the majority of debt owed to its Chairman, Boris (Bary) Molchadsky, who converted approximately $140,000 of debt into AppYea warrants with a strike price of $0.07 per share, reflecting a premium of more than 250% over the current market price of the Company's common shares.
AppYea recently entered its commercial phase with the first deliveries of AppySleep to customers in the United States. Additionally, the Company has launched a new direct sales website, AppySleep.com, and a new e-commerce store on Amazon.
Mr. Molchadsky commented on the conversion, stating, "This conversion demonstrates my utmost confidence in the prospects and business, given the fact I am converting debt into warrants with a strike price set at a substantial premium to the current market price. The Company has made tremendous progress and I do not believe the current market price of the Company's common stock reflects the intrinsic value of our business or robust intellectual property. In particular, after years of development, we have started delivering our first product, AppySleep. There is increasing consumer awareness about the significance of healthy sleep, and our goal is to diagnose and alleviate a variety of major sleep disorders."
AppYea's commitment to innovation and user-centric design marks a new era in sleep wellness. AppySleep is a compact, lightweight, and comfortable smart wristband designed for use during sleep. This wristband seamlessly incorporates multiple sensors and interfaces with the AppySleep smartphone app via Bluetooth. The app, utilizing the smartphone's microphone, actively monitors breathing patterns during sleep. When it detects several consecutive snores, the wristband responds with a gentle vibration, prompting the user to adjust their sleeping position and naturally cease snoring. The key to AppySleep's effectiveness lies in its user-friendly design and gradual training approach. Over continuous use spanning several weeks, users typically acclimate to sleeping in a correct and healthy position, significantly reducing, or eliminating snoring.
About AppYea
AppYea is a Healthtech company commercializing innovative wearable technology for the treatment of snoring and developing wearable solutions to diagnose and treat sleep apnea. The Company's solutions are based on its proprietary IP portfolio of AI and sensing technologies for the tracking and analysis of breathing patterns, vital signs, and other physiological parameters during sleep, designed for greater accuracy at lower and affordable cost. For more information on AppYea please go to Appyea.com.
Cautionary Note Regarding Forward-Looking Statements
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of AppYea are subject to many factors including, but not limited to, the sufficiency or working capital and our ability to raise the capital needed to fund our development efforts, the going concern qualification in our financials, timing of product development, customer acceptance of our products in the market, the introduction of competitive products, the effectiveness of our product distribution networks, the impact of any product liability or other adverse litigation, commercialization and technological difficulties, and the other risks identified in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 filed with the Securities and Exchange Commission on April 1, 2024. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information, or otherwise.
Contact:
Crescendo Communications, LLC
Tel: (212) 671-1020
Email: APYP@Crescendo-IR.com
SOURCE: APPYEA, Inc.
Israel’s tech sector shows resilience despite challenges post-Oct. 7
https://www.jns.org/israels-tech-sector-shows-resilience-despite-challenges-post-oct-7/
Sorry I meant to say GO $APYP
A big step in the right direction. Go $BRLL
$APYP AppYea Launches E-Commerce Store on Amazon Broadening Distribution
https://www.accesswire.com/844979/appyea-launches-e-commerce-store-on-amazon-broadening-distribution
$APYP trending up I see. Getting ready to breakout and run?
🔳🔳Success is *COMING* to APYP: FALCONISHNESS to the extreme?:
*** FALCONISHNESS to the EXTREME? ***
********************
*** I like it a lot? ***
********************
What are your thoughts about this?
$APYP Form 424B3 - Prospectus [Rule 424(b)(3)]
https://ih.advfn.com/stock-market/USOTC/appyea-qb-APYP/stock-news/93359119/form-424b3-prospectus-rule-424b3
$APYP Global Anti-Snoring Devices Market Analysis: 2023 Forecast
Publish Date:February 2024
The global anti-snoring devices market is expected to grow from $1.53 billion in 2022 to $1.67 billion in 2023 at a compound annual growth rate (CAGR) of 9.3%.
North America was the largest region in the anti-snoring devices market in 2022.Asia-Pacific is expected to be the fastest-growing region in the forecast period.
The regions covered in the anti-snoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
I'd be happy with even half that amount.
I think we're gonna have a nice week. More people are talking about APYP.
$APYP Form POS AM - Post-Effective amendments for registration statement
https://ih.advfn.com/stock-market/USOTC/appyea-qb-APYP/stock-news/93238717/form-pos-am-post-effective-amendments-for-regist
|
Followers
|
513
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
52606
|
|
Created
|
10/22/14
|
Type
|
Free
|
| Moderators | |||
Working today for tomorrow's future.
The Diagnostic Center Inc, is a newly formed marketing and service subsidiary of AppYea, Inc. (OTC:APYP) that empowers physician offices, clinics, hospitals, long term care facilities, healthcare groups, employers, governmental units and correctional institutions in getting comprehensive diagnostic testing results quicker. Our goal is to work with multiple diagnostic testing facilities throughout the United States and at the same time using numerous collectors to handle the samples personally therefore expediting the process.
We provide fast and accurate results. With screening results within 24 hours and full confirmation of 78 tests.
https://www.thediagnosticcenters.com/investors/
Boca Raton, FL, and Rehovot, Israel (OTC Pink: APYP) AppYea, Inc. ("AppYea" or the "Company") begun the process to acquire 100% of the outstanding shares of SleepX Ltd., a company formed under the laws of Israel ("SleepX") and Nexense Technologies USA Inc., a Delaware corporation.
Todd Violette, CEO of AppYea stated, "I have been very impressed with the SleepX management team in Israel and SleepXs products and technology. SleepX holds a portfolio of patents and products designed to prevent snoring and sleep apnea, which I believe present a unique opportunity for AppYea."
AppYea management's review of information from Research and Markets September 18, 2020 industry report, indicates the global sleep apnea device market is forecast to increase to US$9.29 billion in 2024, growing at a compounded annual growth rate of 7.94% between 2020-2024. The same report found that the fastest-growing regional market wasNorth America, with the highest incidence of obstructive sleep apnea cases, provided that Europealso represents a large available market.
"SleepX has developed a unique technology for monitoring sleep apnea. The Technology and IP are protected via international patents - sleep apnea detection and sleep phases analysis through sound wave analysis, developed in the Biomedical Department of Ben Gurion University in Beer Sheva, Israel.Based on this technology, one of the leading products SleepX offers is a unique night bracelet for the treatment of snoring using artificial Intelligence", said Bary Molchadsky, CEO of SleepX.
News LINK: https://www.otcmarkets.com/stock/APYP/news/APYP-begin-process-for-Acquisition-of-SleepX-Ltd?id=287757
Boca Raton, FL (OTC Ticker: APYP) Appyea, Inc, on January 28, 2021, announced the entry into a non-binding Letter of Intent (LOI) for the acquisition of SleepX Ltd. from Israel.
https://www.otcmarkets.com/stock/APYP/news/APYP-Update?id=290348
Patent information
https://www.sleepxclear.com/unique-technology
*******************************************************************************************************************************************************************************************************************************************************************
AppYea Holding Inc.
Cannabis Blockchain
One of our subsidiaries, will be going into the Cannabis Blockchain Business. Last year, while I was researching the cannabis industry, I identified some key business models unique to the cannabis industry that are incredibly different from those currently being promoted in the Cannabis Capital Markets. The number one principle that drives the success in the cannabis industry for long term valuation and growth is the principle to acquire the "Customer First." Therefore, building a Cannabis Blockchain for the customers and expanding delivery services that deliver cannabis to people in their homes will be the end target market. I have approved the Subsidiary of AppYea Holding Inc., and the newly formed Canadian Subsidiary will transition, focusing the business development during 2021 on building a Cannabis Blockchain Company.
I view this opportunity based upon the belief that by 2022, California's cannabis market is projected to jump to $5 billion boosted significantly by California's recreational cannabis market. The California cannabis industry's total economic impact could be nearly $10 billion.
The Environmental benefit results from creating a decentralized, encrypted database validating SOP processes as they occur during Cannabis Cultivation. The record's benefit will track the amount of pesticide used, water consumed, and soil degradation.
The Person partaking in the use of the product benefits from a cleaner and better product to enjoy. In the future, we envision the consumer being able to scan the QR code with their phone and use the Blockchain to see the record of the nutrients solution recipe or the amount of pesticide used during the cultivation and packaging process. The end customer will have a history of the Cannabis plant through all stages of the plant's life cycle to verify the final product's product outcome and authenticity.
The Government could begin using the system to be more efficient with tax collections and implementing more effective regulatory policies. We can expect that governments will finally acceptblockchainbenefits and improve critical applications improving tracking financial transactions and ensuring people's identity in the seed to the sale process.
The Cannabis Blockchain cansignificantlyimprove supply chainsby enabling faster and more cost-efficient product deliveries, enhancing product traceability,and enhancingcoordination between customers, drivers, and central locations.
I feel these targeted areas with a combination of proprietary plans will allow the Company to build out a revenue model and use the base assets being developed to potentially generate revenue within the next year. I recently traveled to the Province of Saskatchewan to view a location and meet with a local representative that owns the property for a site that could access power, internet, and host multiple servers. The vision would include developing Agricultural Data and becoming an Ag Tech Datacenter using blockchain technology.
*******************************************************************************************************************************************************************************************************************************************************************
Mr. Todd Violette serves as NEW Chairman of the Board, Chief Executive Officer of the Company. Mr. Violette brings a wealth of experience to AppYea, having spent more than 24 years evaluating and participating investment opportunities across the capital structure of North American companies with a focus on OTC companies. Mr. Violette has worked in a management capacity as a chief executive officer, affecting corporate actions and implementing policies in order to maximize shareholder value. AppYea has previously announced its participation and desire to be in the CBD and Hemp business Mr. Violette disclosed to the Board a potential conflict of interest regarding his outside participation in a project working with a team of experts building 55,000 sq. feet private hemp exaction facility in in Western Kentucky. Any opportunity resulting from this operation will first be brought to AppYea. Mr. Violette graduated of the University of Maryland College Park in 1992.
*******************************************************************************************************************************************************************************************************************************************************************
Contact Information
AppYea Inc.
1-800-674-3561 or Email info@appyea.com
1-800-674-3561 Please Phone or Text Email: info@appyea.com
Twitter Link: https://twitter.com/AppyeaInc/status/1346914866183892994
AI
